307 related articles for article (PubMed ID: 33723056)
41. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
42. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.
Ward SV; George CX; Welch MJ; Liou LY; Hahm B; Lewicki H; de la Torre JC; Samuel CE; Oldstone MB
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):331-6. PubMed ID: 21173229
[TBL] [Abstract][Full Text] [Related]
43. Novel de novo heterozygous frameshift mutation of the ADAR1 gene in heavy dyschromatosis symmetrica hereditaria.
Li CR; Li H; Yu RX; Li ZL; Li Q; Gong JQ
Cutis; 2016 Sep; 98(3):E16-E18. PubMed ID: 27814417
[No Abstract] [Full Text] [Related]
44. Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.
Fritzell K; Xu LD; Otrocka M; Andréasson C; Öhman M
Nucleic Acids Res; 2019 Feb; 47(4):e22. PubMed ID: 30590609
[TBL] [Abstract][Full Text] [Related]
45. A novel nonsense mutation of ADAR1 gene in a Chinese patient with dyschromatosis symmetrica hereditaria.
Wu QY; Li WW; Li N; Li TF; Zhang C; Ni T; Cui YX; Li XJ; Xia XY
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1832-3. PubMed ID: 24673593
[No Abstract] [Full Text] [Related]
46. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
47. 5-HT
Yu W; Xu H; Xue Y; An D; Li H; Chen W; Yu D; Sun Y; Ma J; Tang Y; Xiao Z; Yin S
Brain Behav; 2018 Mar; 8(3):e00929. PubMed ID: 29541541
[TBL] [Abstract][Full Text] [Related]
48. Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias.
Ma CH; Chong JH; Guo Y; Zeng HM; Liu SY; Xu LL; Wei J; Lin YM; Zhu XF; Zheng GG
Biochem Biophys Res Commun; 2011 Mar; 406(2):245-51. PubMed ID: 21316340
[TBL] [Abstract][Full Text] [Related]
49. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
Zhou S; Yang C; Zhao F; Huang Y; Lin Y; Huang C; Ma X; Du J; Wang Y; Long G; He J; Liu C; Zhang P
J Biol Chem; 2019 Nov; 294(48):18168-18180. PubMed ID: 31636123
[TBL] [Abstract][Full Text] [Related]
50. Differential Binding of Three Major Human ADAR Isoforms to Coding and Long Non-Coding Transcripts.
Galipon J; Ishii R; Suzuki Y; Tomita M; Ui-Tei K
Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208661
[TBL] [Abstract][Full Text] [Related]
51. Double MS2 guided restoration of genetic code in amber (TAG), opal (TGA) and ochre (TAA) stop codon.
Bhakta S; Tsukahara T
Enzyme Microb Technol; 2021 Sep; 149():109851. PubMed ID: 34311888
[TBL] [Abstract][Full Text] [Related]
52. Mutation analysis of the ADAR1 gene in a Chinese Family with dyschromatosis symmetrica hereditaria.
Huang Y; Zhao X; Mei Q; Cheng B; Zhao Y; Shangguan Z
Australas J Dermatol; 2014 Feb; 55(1):92-3. PubMed ID: 24433377
[No Abstract] [Full Text] [Related]
53. Mutation analyses of patients with dyschromatosis symmetrica hereditaria: Ten novel mutations of the ADAR1 gene.
Okamura K; Abe Y; Fukai K; Tsuruta D; Suga Y; Nakamura M; Funasaka Y; Oka M; Suzuki N; Wataya-Kaneda M; Seishima M; Hozumi Y; Kawaguchi M; Suzuki T
J Dermatol Sci; 2015 Jul; 79(1):88-90. PubMed ID: 25982145
[No Abstract] [Full Text] [Related]
54. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
Margolis N; Moalem H; Meirson T; Galore-Haskel G; Markovits E; Baruch EN; Vizel B; Yeffet A; Kanterman-Rifman J; Debby A; Besser MJ; Schachter J; Markel G
Cancer Immunol Res; 2022 Sep; 10(9):1127-1140. PubMed ID: 35731225
[TBL] [Abstract][Full Text] [Related]
55. A novel deletion mutation of the ADAR1 gene in a Chinese patient with dyschromatosis symmetrica hereditaria.
Li WW; Wu QY; Li N; Deng DQ; Zhang RS; Cui YX; Li XJ; Xia XY
J Genet; 2014 Aug; 93(2):523-5. PubMed ID: 25189252
[No Abstract] [Full Text] [Related]
56. Identification and characterization of a constitutively expressed Ctenopharyngodon idella ADAR1 splicing isoform (CiADAR1a).
Liu X; Huang K; Hou Q; Sun Z; Wang B; Lin G; Li D; Liu Y; Xu X; Hu C
Dev Comp Immunol; 2016 Oct; 63():10-7. PubMed ID: 27185203
[TBL] [Abstract][Full Text] [Related]
57. Four novel mutations of
Hu W; Shi X; Li H; Chen L; Wang T; Dong Y; Zhang Y; Hu M; Liu X; Zhang C; Liu D; Deng Y
Indian J Dermatol Venereol Leprol; 2019; 85(1):69-73. PubMed ID: 29536976
[TBL] [Abstract][Full Text] [Related]
58. Dyschromatosis symmetrica hereditaria.
Hayashi M; Suzuki T
J Dermatol; 2013 May; 40(5):336-43. PubMed ID: 22974014
[TBL] [Abstract][Full Text] [Related]
59. Dyschromatosis symmetrica hereditaria with chilblains due to a novel two-amino-acid deletion in the double-stranded RNA-binding domain of ADAR1.
Kono M; Suganuma M; Shimada T; Ishikura Y; Watanabe S; Takeichi T; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):e394-e396. PubMed ID: 29775506
[No Abstract] [Full Text] [Related]
60. Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.
Li L; Qian G; Zuo Y; Yuan Y; Cheng Q; Guo T; Liu J; Liu C; Zhang L; Zheng H
J Biol Chem; 2016 Nov; 291(48):24974-24985. PubMed ID: 27729454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
